Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Serina Therapeutics Inc. (SER) Insider Trading Activity
Healthcare • Biotechnology • 9 employees
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Total Value
$10,017,744.55
Total Shares
1,003,866
Average Trade Value
$3,339,248.18
Most Active Insider
Juvenescence Ltd
Total Activity: $10,000,000
Largest Single Transaction
$5,000,000
by Juvenescence Ltd on Jan 31, 2025
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
10% Owner
|
Jan 31, 2025 | 500,000 | $5,000,000 | 3,267,188 (+15.3%) | Grant | |
|
Director
|
Dec 17, 2024 | 3,866 | $17,745 | 67,243 (+5.7%) | Purchase | |
|
10% Owner
|
Nov 27, 2024 | 500,000 | $5,000,000 | 2,767,188 (+18.1%) | Grant |